| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 1985 | 2019 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.390 | None | 1.000 | 4 | 0 | 2006 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 4 | 0 | 1985 | 2020 | ||||||||
|
cadherin 13 | 0.501 | 0.846 | 7.1E-04 |
|
disease | 0.350 | None | 1.000 | 3 | 0 | 2006 | 2017 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 1992 | 2019 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
ribonucleotide reductase regulatory subunit M2 | 0.555 | 0.769 | 0.30 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
glyceraldehyde-3-phosphate dehydrogenase | 0.447 | 0.808 | 0.11 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1988 | 2019 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
solute carrier family 22 member 10 | 0.769 | 0.308 | 1.9E-19 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2009 | 2017 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 1979 | 2018 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
metallothionein 2A | 0.553 | 0.808 | 1.2E-05 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2020 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.340 | None | 1.000 | 2 | 0 | 1991 | 2020 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2004 | 2020 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 1992 | 2016 | ||||||||
|
follistatin | 0.513 | 0.731 | 0.98 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
disease | 0.530 | None | 1.000 | 2 | 0 | 2000 | 2016 |